- Home
- TNON vs BGLC Comparison
TNON vs BGLC Comparison
Compare TNON & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- BGLC
- Stock Information
- Founded
- TNON 2012
- BGLC 2017
- Country
- TNON United States
- BGLC Malaysia
- Employees
- TNON N/A
- BGLC N/A
- Industry
- TNON Medical Specialities
- BGLC Medical Specialities
- Sector
- TNON Health Care
- BGLC Health Care
- Exchange
- TNON Nasdaq
- BGLC Nasdaq
- Market Cap
- TNON 11.5M
- BGLC 10.4M
- IPO Year
- TNON 2022
- BGLC N/A
- Fundamental
- Price
- TNON $1.17
- BGLC $5.70
- Analyst Decision
- TNON Strong Buy
- BGLC
- Analyst Count
- TNON 2
- BGLC 0
- Target Price
- TNON $5.50
- BGLC N/A
- AVG Volume (30 Days)
- TNON 269.5K
- BGLC 176.1K
- Earning Date
- TNON 11-12-2025
- BGLC 11-14-2025
- Dividend Yield
- TNON N/A
- BGLC N/A
- EPS Growth
- TNON N/A
- BGLC N/A
- EPS
- TNON N/A
- BGLC N/A
- Revenue
- TNON $2,947,000.00
- BGLC $9,551,559.00
- Revenue This Year
- TNON $43.52
- BGLC N/A
- Revenue Next Year
- TNON $82.14
- BGLC N/A
- P/E Ratio
- TNON N/A
- BGLC N/A
- Revenue Growth
- TNON N/A
- BGLC 4.01
- 52 Week Low
- TNON $0.85
- BGLC $2.01
- 52 Week High
- TNON $7.51
- BGLC $15.60
- Technical
- Relative Strength Index (RSI)
- TNON 44.55
- BGLC 55.45
- Support Level
- TNON $1.13
- BGLC $4.20
- Resistance Level
- TNON $1.26
- BGLC $5.65
- Average True Range (ATR)
- TNON 0.07
- BGLC 0.34
- MACD
- TNON -0.01
- BGLC 0.01
- Stochastic Oscillator
- TNON 26.09
- BGLC 83.33
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.